Albert Bourla (Greek: Άλμπερτ Μπουρλά; born October 21, 1961) is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions.

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, “Breakthroughs that change patients’ lives,” with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

2 days ago · Pfizer CEO Albert Bourla addresses the audience as part of a session on AI during the World Economic Forum (WEF) annual meeting in Davos on January 23, 2025.

Mar 16, 2023 · Albert Bourla says he never planned to become a CEO. When he joined Pfizer in 1993, after earning a Ph.D. from a veterinary school in Greece, Bourla says he knew his calling was industry, not academia. He said clarity about his true passion has been one of the foundations of his success.

Take a look below to see where Pfizer, and our CEO Albert Bourla, landed on a variety of lists—including TIME’s 100 Most Influential Companies and Forbes America’s Dream Employers—recognizing both our work in the lab and in the office. …

Nov 9, 2021 · Just over a year after assuming the role of chief executive, Bourla found himself facing the unthinkable – a once-in-a-lifetime global pandemic. Bourla and Pfizer reacted quickly to the threat of COVID-19, investing more than $2 billion dollars at-risk in pursuit of a safe and effective vaccine.

When a novel coronavirus struck in early 2020, Pfizer ’s PFE -0.49% chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the drugmaker to deliver a...

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

Jan 13, 2025 · Albert Bourla, Pfizer chairman and CEO, joins CNBC's 'Power Lunch' to discuss the company's focus for 2025, whether bird flu is the next pandemic, and more.